EUVIMEDEUVIMED entdecken
Open Access

Expression of human thrombomodulin by GalTKO.hCD46 pigs modulates coagulation cascade activation by endothelial cells and during ex vivo lung perfusion with human blood

Lars Burdorf iD, Zhuo Gao, Andrea Riner, Evelyn Sievert, Donald G Harris iD, Kasinath V Kuravi, Benson H Morrill, Zahra Habibabady iD, Elana Rybak, Siamak Dahi, Tianshu Zhang, Evan Schwartz und 7 weitere

Xenotransplantation · 2023-11 · 30 (6)

DOI: 10.1111/xen.12828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 28.09.2023. Verfasst von Lars Burdorf und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Protein C, von Willebrand Factor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombomodulin is important for the production of activated protein C (APC), a molecule with significant regulatory roles in coagulation and inflammation. To address known molecular incompatibilities between pig thrombomodulin and human thrombin that affect the conversion of protein C into APC, GalTKO.hCD46 pigs have been genetically modified to express human thrombomodulin (hTBM). The aim of this study was to evaluate the impact of transgenic hTBM expression on the coagulation dysregulation that is observed in association with lung xenograft injury in an established lung perfusion model, with and without additional blockade of nonphysiologic interactions between pig vWF and human GPIb axis. Expression of hTBM was variable between pigs at the transcriptional and protein level. hTBM increased the activation of human protein C and inhibited thrombosis in an in vitro flow perfusion assay, confirming that the expressed protein was functional. Decreased platelet activation was observed during ex vivo perfusion of GalTKO.hCD46 lungs expressing hTBM and, in conjunction with transgenic hTBM, blockade of the platelet GPIb receptor further inhibited platelets and increased survival time. Altogether, our data indicate that expression of transgenic hTBM partially addresses coagulation pathway dysregulation associated with pig lung xenograft injury and, in combination with vWF‐GP1b‐directed strategies, is a promising approach to improve the outcomes of lung xenotransplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Cvon Willebrand FactorAnimalsSwineHumansTransplantation, HeterologousEndothelial CellsThrombomodulinAnimals, Genetically ModifiedLungPerfusion

Stichwörter der Autor:innen

activated protein Ccoagulationex vivo perfusionlungthrombomodulinxenotransplantation

Substanzen

Protein Cvon Willebrand FactorThrombomodulin

Autor:innen und Institutionen

  • Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Surgery, University of Maryland School of Medicine, and VA Maryland Health Care System, Baltimore, Maryland, USA.
  • Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing, China.
  • Revivicor, Inc., Blacksburg, Virginia, USA.
  • Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Lars Burdorf, Donald G Harris, Zahra Habibabady

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Burdorf, L., Gao, Z., Riner, A., Sievert, E., Harris, D. G., Kuravi, K. V., Morrill, B. H., Habibabady, Z., Rybak, E., Dahi, S., Zhang, T., Schwartz, E., Kang, E., Cheng, X., Esmon, C. T., Phelps, C. J., Ayares, D. L., Pierson, R. N., & Azimzadeh, A. M. (2023). Expression of human thrombomodulin by GalTKO.hCD46 pigs modulates coagulation cascade activation by endothelial cells and during ex vivo lung perfusion with human blood. Xenotransplantation, 30(6). https://doi.org/10.1111/xen.12828

Vancouver

Burdorf L, Gao Z, Riner A, Sievert E, Harris DG, Kuravi KV, et al. Expression of human thrombomodulin by GalTKO.hCD46 pigs modulates coagulation cascade activation by endothelial cells and during ex vivo lung perfusion with human blood. Xenotransplantation. 2023;30(6). doi:10.1111/xen.12828

BibTeX
@article{Burdorf2023,
  author = {Burdorf, Lars and Gao, Zhuo and Riner, Andrea and Sievert, Evelyn and Harris, Donald G and Kuravi, Kasinath V and Morrill, Benson H and Habibabady, Zahra and Rybak, Elana and Dahi, Siamak and Zhang, Tianshu and Schwartz, Evan and Kang, Elizabeth and Cheng, Xiangfei and Esmon, Charles T and Phelps, Carol J and Ayares, David L and Pierson, Richard N and Azimzadeh, Agnes M},
  title = {Expression of human thrombomodulin by GalTKO.hCD46 pigs modulates coagulation cascade activation by endothelial cells and during ex vivo lung perfusion with human blood},
  journal = {Xenotransplantation},
  year = {2023},
  volume = {30},
  number = {6},
  doi = {10.1111/xen.12828}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche